|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang H, Fan JH and Qiao YL: Epidemiology,
etiology, and prevention of esophageal squamous cell carcinoma in
China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Watanabe M, Tachimori Y, Oyama T, Toh Y,
Matsubara H, Ueno M, Kono K, Uno T, Ishihara R, Muro K, et al:
Comprehensive registry of esophageal cancer in Japan, 2013.
Esophagus. 18:1–24. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akiyama H, Tsurumaru M, Udagawa H and
Kajiyama Y: Radical lymph node dissection for cancer of the
thoracic esophagus. Ann Surg. 220:364–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Altorki N, Kent M, Ferrara C and Port J:
Three-field lymph node dissection for squamous cell and
adenocarcinoma of the esophagus. Ann Surg. 236:177–183. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koenig AM, Prenzel KL, Bogoevski D,
Yekebas EF, Bubenheim M, Faithova L, Vashist YK, Gawad KA, Baldus
SE, Pantel K, et al: Strong impact of micrometastatic tumor cell
load in patients with esophageal carcinoma. Ann Surg Oncol.
16:454–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okholm C, Svendsen LB and Achiam MP:
Status and prognosis of lymph node metastasis in patients with
cardia cancer-a systematic review. Surg Oncol. 23:140–146. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stein HJ, Feith M, Bruecher BL, Naehrig J,
Sarbia M and Siewert JR: Early esophageal cancer: Pattern of
lymphatic spread and prognostic factors for long-term survival
after surgical resection. Ann Surg. 242:566–575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang M, Li Z, Ma Y, Zhu G, Zhang H and
Xue Y: Prognostic predictors of patients with carcinoma of the
gastric cardia. Hepatogastroenterology. 59:930–933. 2012.PubMed/NCBI
|
|
10
|
Xia W, Liu S, Mao Q, Chen B, Ma W, Dong G,
Xu L and Jiang F: Effect of lymph node examined count on accurate
staging and survival of resected esophageal cancer. Thorac Cancer.
10:1149–1157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Zhang X, Zhang X, Liu-Helmersson
J, Zhang L, Xiao W, Jiang Y, Liu K and Sang S: Prognostic value of
the extent of lymphadenectomy for esophageal cancer-specific
survival among T1 patients. BMC Cancer. 21:4032021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rizk NP, Ishwaran H, Rice TW, Chen LQ,
Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, et al:
Optimum lymphadenectomy for esophageal cancer. Ann Surg. 251:46–50.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu S, Wang Z and Wang F: Optimal
lymphadenectomy for thoracic esophageal cancer: Three-field or
modified two-field lymphadenectomy. Zhonghua Wei Chang Wai Ke Za
Zhi. 19:975–978. 2016.(In Chinese). PubMed/NCBI
|
|
14
|
Zheng Y, Wang Z, Wang F, Huang Q and Liu
S: Proposed modifications of supraclavicular lymph node metastasis
in the esophageal squamous cell carcinoma staging system for
improved survival stratification. Oncotarget. 8:41563–41571. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Y, Hu C, Zhang H, Ping Y and Chen LQ:
How does the number of resected lymph nodes influence TNM staging
and prognosis for esophageal carcinoma? Ann Surg Oncol. 17:784–790.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shapiro J, van Lanschot JJB, Hulshof MCCM,
van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven
HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, et al:
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for
oesophageal or junctional cancer (CROSS): Long-term results of a
randomised controlled trial. Lancet Oncol. 16:1090–1098. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi J, Kim SG, Kim JS, Jung HC and Song
IS: Comparison of endoscopic ultrasonography (EUS), positron
emission tomography (PET), and computed tomography (CT) in the
preoperative locoregional staging of resectable esophageal cancer.
Surg Endosc. 24:1380–1386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Onbaş O, Eroglu A, Kantarci M, Polat P,
Alper F, Karaoglanoglu N and Okur A: Preoperative staging of
esophageal carcinoma with multidetector CT and virtual endoscopy.
Eur J Radiol. 57:90–95. 2006. View Article : Google Scholar
|
|
19
|
Raja S, Rice TW, Murthy SC, Ahmad U,
Semple ME, Blackstone EH and Ishwaran H; Worldwide Esophageal
Cancer Collaboration Investigators, : Value of lymphadenectomy in
patients receiving neoadjuvant therapy for esophageal
adenocarcinoma. Ann Surg. 274:e320–e327. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng YZ, Li XQ, Wang JY, Yang H, Wen J,
Zhai WY, Yuan LX, Fu SS, Liao HY and Fu JH: Impact of examined
lymph node count for esophageal squamous cell carcinoma in patients
who underwent right transthoracic esophagectomy. Ann Surg Oncol.
28:3025–3033. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu
Z, Mao W, Xiang J, Han Y, Chen Z, et al: Neoadjuvant
chemoradiotherapy followed by surgery versus surgery alone for
locally advanced squamous cell carcinoma of the esophagus
(NEOCRTEC5010): A phase III multicenter, randomized, open-label
clinical trial. J Clin Oncol. 36:2796–2803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelly RJ, Ajani JA, Kuzdzal J, Zander T,
Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre
A, et al: Adjuvant nivolumab in resected esophageal or
gastroesophageal junction cancer. N Engl J Med. 384:1191–1203.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li B, Zhang Y, Miao L, Ma L, Luo X, Zhang
Y, Ye T, Li H, Zhang J, Li Y, et al: Esophagectomy with three-field
versus two-field lymphadenectomy for middle and lower thoracic
esophageal cancer: Long-term outcomes of a randomized clinical
trial. J Thorac Oncol. 16:310–317. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu L, Zhang XT, Guan SH, Cheng YF and Li
LX: The number of negative lymph nodes is positively associated
with survival in esophageal squamous cell carcinoma patients in
China. Open Med (wars). 15:152–159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo X, Wang Z, Yang H, Mao T, Chen Y, Zhu
C, Yu Z, Han Y, Mao W, Xiang J, et al: Impact of lymph node
dissection on survival after neoadjuvant chemoradiotherapy for
locally advanced esophageal squamous cell carcinoma: From the
results of NEOCRTEC5010, a randomized multicenter study. Ann Surg.
227:259–266. 2023. View Article : Google Scholar
|
|
26
|
Chao YK, Liu HP, Hsieh MJ, Wu YC, Liu YH,
Yeh CH, Chang HK and Tseng CK: Lymph node dissection after
chemoradiation in esophageal cancer: A subgroup analysis of
patients with and without pathological response. Ann Surg Oncol.
19:3500–3505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chinese society of clinical oncology
(CSCO), . Guidelines of the Chinese Society of Clinical Oncology
(CSCO) Esophageal Cancer. 2022.(In Chinese).
|
|
28
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. 8th edition.
Springer; New York: 2017, View Article : Google Scholar
|
|
29
|
Tachimori Y, Ozawa S, Numasaki H,
Matsubara H, Shinoda M, Toh Y, Udagawa H, Fujishiro M, Oyama T and
Uno T; Registration Committee for Esophageal Cancer of the Japan
Esophageal Society, : Efficacy of lymph node dissection by node
zones according to tumor location for esophageal squamous cell
carcinoma. Esophagus. 13:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
